Journey Medical Corp
▲ 0 upgrades / ▼ 0 downgrades / 0 reiterations from 0 firms
Nov 11, 2026 (16 days)
| Date ▼ | Firm | Action | From → To Rating | Price Target | Firm Rating |
|---|---|---|---|---|---|
| Aug 13, 2026 | B. Riley Securities | reiterate | Buy → Buy | — | 55% |
| Mar 26, 2026 | HC Wainwright & Co. | reiterate | Buy → Buy | — | 44% |
| Aug 25, 2025 | HC Wainwright & Co. | initiate | — → Buy | $13 | 44% |
| Aug 13, 2025 | Lake Street | maintain | Buy → Buy | $13 | 47% |
| Jul 30, 2025 | B. Riley Securities | maintain | Buy → Buy | $12 | 55% |
| Feb 16, 2024 | Alliance Global Partners | initiate | — → Buy | $8.5 | 41% |
| Sep 7, 2023 | B. Riley Securities | reiterate | Buy → Buy | $6 | 55% |
| Jul 12, 2023 | B. Riley Securities | maintain | Buy → Buy | $6 | 55% |
| May 23, 2023 | B. Riley Securities | maintain | Buy → Buy | $3 | 55% |
| Mar 30, 2023 | B. Riley Securities | reiterate | — → Buy | $6 | 55% |
| Feb 25, 2022 | Cantor Fitzgerald | initiate | — → Overweight | $9 | 50% |
| Dec 16, 2021 | Roth Capital | initiate | — → Buy | $15 | 53% |
| Dec 7, 2021 | B. Riley Securities | initiate | — → Buy | $14 | 55% |
No cross-platform signals in the last 90 days